Win-Win strategic alliances between domestic firms and foreign-invested firms eyed

Published: 2002-07-18 07:00:00

Updated: 2002-07-18 07:00:00

Market observers says that the win-win strategic alliances between domestic firms and foreign-investment firms need to be further strengthened for co-marketing and/or co-development of new drugs to effectively minimize outlays for sales and development of new drugs, in the midst where many foreig...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK